Hem › Dermatomyosit › North Carolina
Kliniska studier för Dermatomyosit i North Carolina
8 studier för Dermatomyosit söker deltagare vid platser i North Carolina.
Städer i North Carolina
Officiell studietext (engelska)
Environmental Risk Factors for the Anti-synthetase Syndrome
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 2 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT01276470A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Charlotte
- Research Site, Durham
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06455449Adult and Juvenile Myositis
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 2 till 100 · Alla kön · Uppdaterad 24 sep. 2026 · NCT00017914RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
RekryterarFas 2/3
Ålder 6 till 75 · Alla kön · Uppdaterad 17 sep. 2026 · NCT06154252A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Chapel Hill
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 15 sep. 2026 · NCT06916806A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Atrium Health Rheumatology-Southpark, Charlotte
- Duke University Medical Center, Durham
RekryterarFas 1
Ålder 18 till 74 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07085104Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Universtity of North Carolina at Chapel Hill, Chapel Hill
RekryterarFas 1
Ålder 18 till 85 · Alla kön · Uppdaterad 22 juli 2026 · NCT06371417A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Duke University, Durham
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 14 juli 2026 · NCT07115745Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.